Price movement over the last 24 hours
ARK Genomic Revolution ETF vs Corning Incorporated — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while Corning Incorporated trades at $185.12 (market cap $164.29B). The key difference: Corning Incorporated pays a 0.59% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Corning Incorporated nearer its low. Which is the better fit depends on your goals.
| ARKG | GLW | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $255.79 |
52-Week Low | $23.09 | $51.60 |
Market Cap | — | $164.29B |
Enterprise Value | — | $172.46B |
Dividend Yield | — | 0.59% |
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
GLW trades at $190.85, down 0.87% on the day, with a bullish technical signal supported by moving averages and oversold RSI-6 at 12.45. Recent earnings beats in Q3 2025-Q1 2026 and strong 2025 revenue growth to $15.63B highlight fundamental strength. Analyst consensus is bullish with a $208.60 price target, though high P/E of 91.77 raises valuation concerns. News outlets like Barron's (July 10, 2026) note AI-driven partnerships as a key catalyst amid recent volatility.
Outlook remains positive with AI infrastructure demand fueling growth, but risks include elevated debt levels and competitive pressures. The stock offers a dividend yield of approximately 0.29% with consistent payouts. Investors should weigh robust earnings momentum against rich valuations and macroeconomic headwinds for balanced exposure.
Trailing returns across standard periods
Latest headlines on both assets
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Corning Inc is a leader in materials science, specializing in the production of glass, ceramics and optical fiber. The firm supplies its products for a wide range of applications, from flat-panel displays in televisions to gasoline particulate filters in automobiles to optical fiber for broadband access, with a leading share in many of its end markets.
Read more on GLW →